Billionaire Steve Cohen’s Top 15 Stock Picks

Page 10 of 15

6. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 92

Point72 Asset Management’s Stake: $283.4 million   

Boston Scientific Corporation (NYSE:BSX) is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The following reasons highlight the company’s strength as an investment target. Firstly, as per the report of the third quarter of 2024, the company generated net sales of $4.209 billion, growing 19.4% on a reported basis, 19.5% on an operational basis, and 18.2% on an organic basis, all compared to the prior year period. Secondly, the company has entered into a definitive agreement to acquire Silk Road Medical and develop an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called trans carotid artery revascularization (TCAR). The purchase price is $27.50 per share, reflecting an enterprise value of approximately $1.16 billion.

Page 10 of 15